CLINICAL TRIAL PHASE 3 VACCINE COVID-19 BUMN

Minister of BUMN Erick Thohir (center) along Deputy Minister of Health Dante Saksono Harbuwono (second right), Head BPOM RI Penny K Lukito (second left), President Director of PT Bio Farma Honesti Basyir (left), and Chief Research Center Semarang Faculty of Medicine Diponegoro Yeti University (right) provides an overview of Klinis Fase 3 Vaccine COVID-19 BUMN in Semarang, Central Java, Thursday (9/6/2022). The COVID-19 BUMN collaboration of PT Biofarma, Baylor College of Medicine, and Eijkman uses a sub-unit recombinant protein platform targeted to obtain Emergency Edar License (Emergency Use Authorization/UEA) on July 2022 came with a preparation of production capacity of 120 million doses per year. ANTARA PHOTO/Aji Styawan/YU

The caption is automatically translated by application. Click here for the Bahasa Indonesia version.